Loading

Patient-centric by design: creating therapies with the patient in mind

11 Feb 2026
Theatre 3
Clinical and translational excellence

Incorporating patient-centric principles can improve trial design, translational fidelity, and clinical impact in advanced therapy development. This session examines methods to embed patient input, optimize endpoints, and align program design with real-world patient considerations.

Key takeaways

  • Integrate patient perspectives into study design and endpoint selection
  • Align biomarker strategies with patient-relevant outcomes
  • Enhance translational fidelity by considering patient heterogeneity
  • Implement frameworks that improve trial accessibility and engagement
  • Prioritize decision-making that reflects meaningful clinical benefit for patients
Chairperson
George​ Eastwood​, Executive Director - Emily Whitehead Foundation
Speakers
Amy Christenson, Executive Director, Medical Affairs - Beacon Therapeutics
Adrienne​ Mendoza, Chief Operative Office (COO) - BBG Advanced Therapies
Robert Tressler, CSO & Co-founder - Excellos
Abigail Jastrab, Director, Patient Engagement and Clinical Innovation - PANTHERx Rare
Farhatullah Syed, Group Leader/Senior Scientist ,Head of Advance Cell and Gene Therapy Section, Cancer Center of Excellence (CCoE) - King Faisal Specialist Hospital & Research Centre (KFSH&RC),